{"gao_id": "GAO-21-443", "published": "2021-04-14T12:00:00Z", "released": "2021-04-14T08:00:00Z", "summary": "We reviewed COVID-19 vaccine availability and initial vaccine distribution and administration. We found: The government has taken steps to make more doses available, such as helping vaccine companies expand manufacturing capacity Manufacturing and distribution must increase significantly to make enough doses available for all adults, so managing public expectations is key Associations representing state and local health officials reported challenges such as not knowing how...", "title": "COVID-19: Efforts to Increase Vaccine Availability and Perspectives on Initial Implementation", "topics": ["Clinical trials", "Pharmacy", "Disease control", "Health care centers", "Government contracts", "pandemics", "Public health emergencies", "Vaccinations", "Health Care", "Health care providers", "Emergency management", "Intellectual property", "Public health", "Health care", "Manufacturing"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-21-443", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-21-443-highlights.pdf"}, {"title": "Full Report (53 pages)", "url": "https://www.gao.gov/assets/gao-21-443.pdf"}, {"title": "Accessible PDF (66 pages)", "url": "https://www.gao.gov/assets/720/713756.pdf"}]}